beta

AGE

AgeX Therapeutics, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.

Market Cap: 58.4 Million

Primary Exchange: NYSE American

Website: http://www.agexinc.com

Shares Outstanding: 37.6 Million

Float: 21 Million

Dividend: (%)

Beta: 1.61788093761246

Sector: Health Technology

Industry: Pharmaceuticals: Major

Ethical Flags

Longest drawdown: 268 trading days

From: 2018-12-03 To: 2019-12-09

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud